#USA #New York #Class Action #Dentsply Sirona #XRAY

Join the Class Action Against Dentsply Sirona Inc. (NASDAQ: XRAY)

In a significant legal development, shareholders of Dentsply Sirona Inc., a prominent player in the dental products industry, are being urged to take action by joining a class action lawsuit. The Gross Law Firm has issued notices to investors who purchased shares of Dentsply Sirona within a specific time frame. This class action arises from serious allegations regarding the company's business practices and their impact on patient health and shareholder value.

Key Dates and Registration Process

The deadline to register for participation in this class action suit is January 27, 2025. Shareholders who bought shares of XRAY from December 1, 2022, to November 6, 2024, are particularly encouraged to come forward. Registration is simple and provides shareholders with portfolio monitoring software to keep them updated throughout the legal proceedings.

To register, shareholders can visit the Gross Law Firm's website and submit the necessary details. Importantly, individuals don’t need to be appointed as lead plaintiffs to qualify for recovery under this class action.

Allegations Against Dentsply Sirona

The lawsuit outlines several serious allegations against Dentsply Sirona, claiming that the company engaged in practices that potentially harmed patients while misrepresenting the safety and efficacy of its products. Among the key allegations are:
1. Targeting Vulnerable Populations: The company is accused of specifically targeting low-income individuals lacking adequate oral health education, thereby entering them into dental treatment programs they might not qualify for due to undisclosed dental issues.
2. Sales Pressure and Patient Safety: The complaint suggests that aggressive sales tactics led representatives to prioritize commissions over patient safety, pushing unsuitable treatments to individuals with contraindications.
3. Failure to Report Injuries: The lawsuit claims that Dentsply was aware of numerous patient injuries linked to its Byte aligners yet failed to take appropriate action, including proper notification to the FDA, which is critical for ongoing patient safety regulations.
4. Misleading Financial Statements: Due to these practices, Dentsply allegedly overstated the value of its Byte revenue streams, leading to artificially inflated stock prices that ultimately hurt investors.

Importance of Participation

This class action serves as a crucial mechanism for investors to seek redress for potential losses suffered as a result of the company's alleged misconduct. Participating in such lawsuits not only helps in recovering losses but also promotes accountability among corporations in adhering to ethical practices and transparency.

By coming together, shareholders can strengthen their case, emphasize their collective concerns, and push for necessary changes within the company's governance practices to prevent future incidents.

The Gross Law Firm has established a strong reputation for standing up for investors' rights, and their efforts in this case signal a commitment to uncovering the truth and seeking justice for those affected.

In conclusion, shareholders of Dentsply Sirona are urged to take action swiftly before the January 27 deadline and ensure their voices are heard in this significant legal fight. For more details and to register, please visit the Gross Law Firm's dedicated class action page.